Abstract:Keywords: biocompatible DNA-encoded library parallel synthesis selenium References 1. Rayman MP . Selenium and human health . Lancet 379(9822), 1256–1268 ( 2012 ).Medline CAS Google Scholar 2. Hou W, Xu H . Incorporating selenium into heterocycles and natural products-from chemical properties to pharmacological activities . J. Med. Chem. 65(6), 4436–4456 ( 2022 ).Medline CAS Google Scholar 3. Wrobel JK, Power R, Toborek M . Biological activity of selenium: revisited . IUBMB Life 68(2), 97–105 ( 2016 ).Medline CAS Google Scholar 4. Leszczynska G, Cypryk M, Gostynski B et al. C5-substituted 2-selenouridines ensure efficient base pairing with guanosine; consequences for reading the NNG-3′ synonymous mRNA codons . Int. J. Mol. Sci. 21(8), 2882 ( 2020 ).Medline CAS Google Scholar 5. Hou W, Dong H, Zhang X, Wang Y, Su L, Xu H . Selenium as an emerging versatile player in heterocycles and natural products modification . Drug Discov. Today 27(8), 2268–2277 ( 2022 ).Medline CAS Google Scholar 6. Alhasan R, Nasim MJ, Jacob C, Gaucher C . Selenoneine: a unique reactive selenium species from the blood of tuna with implications for human diseases . Curr. Pharmacol. Reports. 5(3), 163–173 ( 2019 ).CAS Google Scholar 7. Feng X, Pan L, Qian Z et al. Discovery of selenium-containing STING agonists as orally available antitumor agents . J. Med. Chem. 65(22), 15048–15065 ( 2022 ).Medline CAS Google Scholar 8. Rech TDST, Ribeiro EH, Castro ET et al. Antidepressant potential of a functionalized 3-selanyl benzo[b]furan compound in mice: focus on the serotonergic system . ACS Chem. Neurosci. 14(6), 1181–1192 ( 2023 ).Medline CAS Google Scholar 9. Deng X, Xie B, Li Q et al. Discovery of novel bicyclic phenylselenyl-containing hybrids: an orally bioavailable, potential, and multiacting class of estrogen receptor modulators against endocrine-resistant breast cancer . J. Med. Chem. 65(11), 79 -Abstract Truncated-

Selenization of Small Molecule Drugs: A New Player on the Board

Organoselenium Compounds as Novel Adjuvants of Chemotherapy Drugs—A Promising Approach to Fight Cancer Drug Resistance

Following the Trace of Cyclodextrins on the Selenium and Tellurium Odyssey

Seleno-Warfare against Cancer: Decoding Antitumor Activity of Novel Acylselenoureas and Se-Acylisoselenoureas

Seleno Containing Compounds as Potent and Selective Antifungal Agents

Organoselenium compounds in medicinal chemistry

Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development

Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds

Selenium: the emerging element in the medicinal chemist's toolkit

Selenium-Based Drug Development for Antioxidant and Anticancer Activity

Small molecule selenium-containing compounds: Recent development and therapeutic applications

Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics

Selenium and Clinical Trials: New Therapeutic Evidence for Multiple Diseases

Selenium as an emerging versatile player in heterocycles and natural products modification

Biogenic selenium nanoparticles and selenium/chitosan-Nanoconjugate biosynthesized by Streptomyces parvulus MAR4 with antimicrobial and anticancer potential

Recent Advances for the Synthesis of Selenium-containing Small Molecules As Potent Antitumor Agents.

Synthesis and Potential Anticancer Activity of Some Novel Selenocyanates and Diselenides

New Organoselenium (NSAIDs-Selenourea and Isoselenocyanate) Derivatives as Potential Antiproliferative Agents: Synthesis, Biological Evaluation and in Silico Calculations

Selenium-Containing Agents Acting on Cancer—A New Hope?

From Selenite To Diselenide-Containing Drug Delivery Systems

Formulation Studies with Cyclodextrins for Novel Selenium NSAID Derivatives